1. Hoda SA, Hoda RS. Robbins and Cotran pathologic basis of
disease. Am J Clin Pathol. 2020;154(6):869. doi: 10.1093/
ajcp/aqaa163.
2. Morphologia. Junqueira’s Basic Histology: Text & Atlas
(15th ed.), 2018. Morphologia. 2019;13(2):101-4. doi:
10.26641/1997-9665.2019.3.101-104.
3. Leung AM, Braverman LE. Consequences of excess iodine.
Nat Rev Endocrinol. 2014;10(3):136-42. doi: 10.1038/
nrendo.2013.251.
4. Ragusa F, Fallahi P, Elia G, Gonnella D, Paparo SR, Giusti C,
et al. Hashimotos’ thyroiditis: epidemiology, pathogenesis,
clinic and therapy. Best Pract Res Clin Endocrinol Metab.
2019;33(6):101367. doi: 10.1016/j.beem.2019.101367.
5. Muller I, Moran C, Lecumberri B, Decallonne B, Robertson N,
Jones J, et al. 2019 European Thyroid Association guidelines
on the management of thyroid dysfunction following immune
reconstitution therapy. Eur Thyroid J. 2019;8(4):173-85. doi:
10.1159/000500881.
6. Brandt F, Thvilum M, Almind D, Christensen K, Green A,
Hegedüs L, et al. Hyperthyroidism and psychiatric morbidity:
evidence from a Danish nationwide register study. Eur J
Endocrinol. 2014;170(2):341-8. doi: 10.1530/eje-13-0708.
7. Thvilum M, Brandt F, Almind D, Christensen K, Brix TH,
Hegedüs L. Type and extent of somatic morbidity before and
after the diagnosis of hypothyroidism. a nationwide register
study. PLoS One. 2013;8(9):e75789. doi: 10.1371/journal.
pone.0075789.
8. Liyanage YS, Siriwardhana ID, Dissanayake M, Dayanath BK.
Study on diurnal variation in TSH and freeT4 levels of healthy
adults. Sri Lanka J Diabetes Endocrinol Metab. 2018;8(1):8-
16. doi: 10.4038/sjdem.v8i1.7346.
9. Paragliola RM, Di Donna V, Locantore P, Papi G, Pontecorvi
A, Corsello SM. Factors predicting time to TSH normalization
and persistence of TSH suppression after total thyroidectomy
for Graves’ disease. Front Endocrinol (Lausanne). 2019;10:95.
doi: 10.3389/fendo.2019.00095.
10. Murillo-Llorente MT, Fajardo-Montañana C, Pérez-Bermejo M.
Reference values of thyroid hormones during the first trimester
of pregnancy in Valencian community (Spain) and their
relationship with iodine intake. Nutrients. 2020;12(5):1433.
doi: 10.3390/nu12051433.
11. Fatourechi V, Klee GG, Grebe SK, Bahn RS, Brennan MD,
Hay ID, et al. Effects of reducing the upper limit of normal
TSH values. JAMA. 2003;290(24):3195-6. doi: 10.1001/
jama.290.24.3195-b.
12. Tonetti MS, Greenwell H, Kornman KS. Staging and grading of
periodontitis: framework and proposal of a new classification
and case definition. J Periodontol. 2018;89 Suppl 1:S159-72.
doi: 10.1002/jper.18-0006.
13. Genco RJ, Borgnakke WS. Risk factors for periodontal disease.
Periodontol 2000. 2013;62(1):59-94. doi: 10.1111/j.1600-
0757.2012.00457.x.
14. Aldulaijan HA, Cohen RE, Stellrecht EM, Levine MJ, Yerke
LM. Relationship between hypothyroidism and periodontitis:
a scoping review. Clin Exp Dent Res. 2020;6(1):147-57. doi:
10.1002/cre2.247.
15. Noguchi S, Yatera K, Kawanami T, Yamasaki K, Naito K, Akata
K, et al. The clinical features of respiratory infections caused
by the Streptococcus anginosus group. BMC Pulm Med.
2015;15:133. doi: 10.1186/s12890-015-0128-6.
16. Wu C, Zhang Y, Gong Y, Hou Y, Li S, Zou Y, et al. Two cases
of bacterial suppurative thyroiditis caused by Streptococcus
anginosus. Endocr Pathol. 2013;24(1):49-53. doi: 10.1007/
s12022-013-9236-0.
17. Kumagai K, Sugano N, Takane M, Iwasaki H, Tanaka H,
Yoshinuma N, et al. Detection of Streptococcus anginosus
from saliva by real-time polymerase chain reaction. Lett
Appl Microbiol. 2003;37(5):370-3. doi: 10.1046/j.1472-
765x.2003.01405.x.
18. Baloch Z, Carayon P, Conte-Devolx B, Demers LM,
FeldtRasmussen U, Henry JF, et al. Laboratory medicine practice
guidelines. Laboratory support for the diagnosis and
monitoring of thyroid disease. Thyroid. 2003;13(1):3-126.
doi: 10.1089/105072503321086962.
19. Pearce SH, Brabant G, Duntas LH, Monzani F, Peeters RP,
Razvi S, et al. 2013 ETA guideline: management of subclinical
hypothyroidism. Eur Thyroid J. 2013;2(4):215-28. doi:
10.1159/000356507.
20. Surks MI, Hollowell JG. Age-specific distribution of serum
thyrotropin and antithyroid antibodies in the US population:
implications for the prevalence of subclinical hypothyroidism.
J Clin Endocrinol Metab. 2007;92(12):4575-82. doi: 10.1210/
jc.2007-1499.
21. Bremner AP, Feddema P, Leedman PJ, Brown SJ, Beilby JP,
Lim EM, et al. Age-related changes in thyroid function: a
longitudinal study of a community-based cohort. J Clin
Endocrinol Metab. 2012;97(5):1554-62. doi: 10.1210/
jc.2011-3020.
22. Lee YK, Kim JE, Oh HJ, Park KS, Kim SK, Park SW, et al.
Serum TSH level in healthy Koreans and the association of
TSH with serum lipid concentration and metabolic syndrome.
Korean J Intern Med. 2011;26(4):432-9. doi: 10.3904/
kjim.2011.26.4.432.
23. Boucai L, Surks MI. Reference limits of serum TSH and
free T4 are significantly influenced by race and age in an
urban outpatient medical practice. Clin Endocrinol (Oxf).
2009;70(5):788-93. doi: 10.1111/j.1365-2265.2008.03390.x.
24. Beydoun MA, Beydoun HA, Kitner-Triolo MH, Kaufman
JS, Evans MK, Zonderman AB. Thyroid hormones are
associated with cognitive function: moderation by sex,
race, and depressive symptoms. J Clin Endocrinol Metab.
2013;98(8):3470-81. doi: 10.1210/jc.2013-1813.
25. Surks MI, Boucai L. Age- and race-based serum thyrotropin
reference limits. J Clin Endocrinol Metab. 2010;95(2):496-
502. doi: 10.1210/jc.2009-1845.
26. Svare A, Nilsen TI, Bjøro T, Asvold BO, Langhammer A.
Serum TSH related to measures of body mass: longitudinal
data from the HUNT Study, Norway. Clin Endocrinol (Oxf).
2011;74(6):769-75. doi: 10.1111/j.1365-2265.2011.04009.x.
27. Chen C, Xia F, Chen Y, Zhang K, Cheng J, Li Q, et al.
Association between thyroid-stimulating hormone and renal
function: a Mendelian randomization study. Kidney Blood
Press Res. 2018;43(4):1121-30. doi: 10.1159/000491808.
28. Kats L, Goldman Y, Kahn A, Goldman V, Gorsky M. Oral lichen
planus and thyroid gland diseases: possible associations.
BMC Oral Health. 2019;19(1):169. doi: 10.1186/s12903-
019-0859-5.
29. Jayanthi R, Srinivasan AR, Hanifah M, Maran AL. Associations
among insulin resistance, triacylglycerol/high density
lipoprotein (TAG/HDL ratio) and thyroid hormone levels-a
study on type 2 diabetes mellitus in obese and overweight
subjects. Diabetes Metab Syndr. 2017;11 Suppl 1:S121-6.
doi: 10.1016/j.dsx.2016.12.020.
30. Șandru F, Carsote M, Petca RC, Gheorghisan-Galateanu AA,
Petca A, Valea A, et al. COVID-19-related thyroid conditions
(Review). Exp Ther Med. 2021;22(1):756. doi: 10.3892/
etm.2021.10188.
31. Albrecht D, Ittermann T, Thamm M, Grabe HJ, Bahls M,
Völzke H. The association between thyroid function
biomarkers and attention deficit hyperactivity disorder. Sci
Rep. 2020;10(1):18285. doi: 10.1038/s41598-020-75228-w.
32. Unüvar T, Anık A, Catlı G, Esen I, Abacı A, Büyükgebiz A,
et al. Isolated hyperthyrotropinemia in childhood obesity and
its relation with metabolic parameters. J Endocrinol Invest.
2014;37(9):799-804. doi: 10.1007/s40618-014-0100-y.
33. Wolters B, Lass N, Reinehr T. TSH and free triiodothyronine
concentrations are associated with weight loss in a lifestyle
intervention and weight regain afterwards in obese children. Eur
J Endocrinol. 2013;168(3):323-9. doi: 10.1530/eje-12-0981.
34. Bauer DC, Ettinger B, Nevitt MC, Stone KL. Risk for fracture in
women with low serum levels of thyroid-stimulating hormone.
Ann Intern Med. 2001;134(7):561-8. doi: 10.7326/0003-
4819-134-7-200104030-00009.
35. Venkatesh Babu NS, Patel PB. Oral health status of children
suffering from thyroid disorders. J Indian Soc Pedod Prev
Dent. 2016;34(2):139-44. doi: 10.4103/0970-4388.180443.
36. McAninch EA, Bianco AC. Thyroid hormone signaling in
energy homeostasis and energy metabolism. Ann N Y Acad
Sci. 2014;1311:77-87. doi: 10.1111/nyas.12374.
37. Li D, Li J, Li C, Chen Q, Hua H. The association of thyroid
disease and oral lichen planus: a literature review and metaanalysis.
Front Endocrinol (Lausanne). 2017;8:310. doi:
10.3389/fendo.2017.00310.
38. Guarneri F, Giuffrida R, Di Bari F, Cannavò SP, Benvenga
S. Thyroid autoimmunity and lichen. Front Endocrinol
(Lausanne). 2017;8:146. doi: 10.3389/fendo.2017.00146.
39. Tang Y, Shi L, Jiang B, Zhou Z, Shen X. A cross-sectional
study of oral lichen planus associated with thyroid diseases
in East China. Front Endocrinol (Lausanne). 2019;10:928. doi:
10.3389/fendo.2019.00928.
40. Robledo-Sierra J, Landin-Wilhelmsen K, Nyström HF,
Mattsson U, Jontell M. Clinical characteristics of patients with
concomitant oral lichen planus and thyroid disease. Oral Surg
Oral Med Oral Pathol Oral Radiol. 2015;120(5):602-8. doi:
10.1016/j.oooo.2015.08.001.
41. Zahid TM, Wang BY, Cohen RE. The effects of thyroid
hormone abnormalities on periodontal disease status. J Int
Acad Periodontol. 2011;13(3):80-5.
42. Bhankhar RR, Hungund S, Kambalyal P, Singh V, Jain K. Effect
of nonsurgical periodontal therapy on thyroid stimulating
hormone in hypothyroid patients with periodontal diseases.
Indian J Dent Res. 2017;28(1):16-21. doi: 10.4103/ijdr.
IJDR_174_16.
43. Tüysüz B, Beker DB. Thyroid dysfunction in children with
Down’s syndrome. Acta Paediatr. 2001;90(12):1389-93. doi:
10.1080/08035250152708770.
44. Biondi B, Kahaly GJ, Robertson RP. Thyroid dysfunction and
diabetes mellitus: two closely associated disorders. Endocr
Rev. 2019;40(3):789-824. doi: 10.1210/er.2018-00163.
45. Jali MV, Kambar S, Jali SM, Pawar N, Nalawade P. Prevalence
of thyroid dysfunction among type 2 diabetes mellitus
patients. Diabetes Metab Syndr. 2017;11 Suppl 1:S105-8. doi:
10.1016/j.dsx.2016.12.017.
)